Outstanding Result For Affiris Alzheimer’s Vaccine In The Latest Thomson “The Ones To Watch” Ranking

The Alzheimer’s vaccine AD01 from AFFIRIS GmbH has been listed in first place in an analysis conducted by the international ranking agency Thomson Scientific into the prospects for success of current clinical trials. The ranking assesses the prospects of clinical trials around the world, regardless of the disease in question. The Austrian company’s Alzheimer’s vaccine was described as one of the “most promising drugs entering Phase I trials”. [click link for full article]

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on December 20th, 2007